FindTrial
Sign In

Comparison of pain relief in the postoperative period with Continuous epidural infusion and Patient controlled epidural device for patients undergoing major abdominal oncologic surgeries

Comparison of patient controlled epidural analgesia (PCEA) with continuous epidural analgesia (CEA) for postoperative pain management after major abdominal oncologic surgeries :A Prospective Randomised Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/01/022973
Enrollment
56
Registered
2020-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C189- Malignant neoplasm of colon, unspecified Health Condition 2: C259- Malignant neoplasm of pancreas, unspecified Health Condition 3: C19- Malignant neoplasm of rectosigmoidjunction Health Condition 4: C20- Malignant neoplasm of rectum Health Condition 5: C569- Malignant neoplasm of unspecifiedovary Health Condition 6: C55- Malignant neoplasm of uterus, partunspecified

Interventions

Intervention1: Patient Controlled Epidural Analgesia: Epidural catheter will be connected to a Patient Controlled Analgesia (PCA) device (B Bruan Spacer Perfusion, USA) ,All patients will be maintaine

Sponsors

St Johns Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients above age of 18 years to 59 years belonging to ASA I, II, III undergoing major abdominal oncologic surgery in St. Johnâ??s Medical College Hospital during the study period.

Exclusion criteria

Exclusion criteria: Patients who have a clinical or laboratory contraindication to the placement of an epidural catheter like bleeding diathesis, severe hypovolemia, elevated intracranial pressure (particularly with an intracranial mass), severe aortic stenosis, severe mitral stenosis and infection at the site of injection. Inability to use the PCEA device Patient posted for Gastrectomy. Patients who have a known allergy to the local anaesthetic or opioid used Patient refusal

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of PCEA and CEA in post op pain management in terms of a) VAS scores measured hourly for 48 hours. b) Requirement of rescue analgesia c) Cumulative dose of local anaesthetic at the end of 48 hours. Timepoint: To compare the efficacy of PCEA and CEA in post op pain management in terms of a) VAS scores measured hourly for 48 hours. b) Requirement of rescue analgesia c) Cumulative dose of local anaesthetic at the end of 48 hours.—

Secondary

MeasureTime frame
a) To compare patient satisfaction in PCEA with CEA in the postoperative period b) To compare the incidence of side effects (Hypotension, Motor Weakness, Numbness. Nausea and Vomiting, Sedation, Pruritus, Respiratory depression, Postoperative ileus) Timepoint: At the end of 48 hours—

Countries

India

Contacts

Public ContactROSY JACOB

St. Johns Medical College

bindu575@gmail.com9342552324

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026